Anyone and everything associated with VVUS will have to compete with .32 cents a pill manufacturers.Arena's patents go past 2023 and are the only valid ones in this entire debacle.
You mean ARNA will have to compete against those .32 cent generic pills too? Yikes, sounds like ARNA is a sell.
Congrats to ARNA for having a patent on a drug that is the equivalent to a placebo + 5%...ooooo, sell off the cows, Martha! We've got us a weiner here...#$%$